Fucoidan: Structure–activity relationships, molecular mechanisms, and nanotherapeutic applications with perspectives from Traditional Chinese Medicine
- 1Marine Nanobiotechnology Laboratory, Department of ENT, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Thandalam, Chennai 602105, Tamil Nadu, India
- 2Natural Biomedicine Laboratory, Department of Dermatology, Saveetha Medical College and Hospital (SMCH), Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Thandalam, Chennai 602105, Tamil Nadu, India
Abstract
Introduction Fucoidan is a sulfated polysaccharide derived from brown macroalgae that has attracted considerable attention due to its diverse biological activities and therapeutic potential. Its bioactivity is closely associated with structural characteristics such as molecular weight, sulfation pattern, monosaccharide composition, and branching architecture. Methods This narrative review summarizes recent advances in fucoidan research, focusing on its sources, structural characteristics, structure–activity relationships, molecular mechanisms, biological activities, nanotherapeutic applications, and perspectives from Traditional Chinese Medicine (TCM). Results Fucoidan exhibits a broad spectrum of biological activities, including antioxidants, anti-inflammatory, anticoagulant, antiviral, immunomodulatory, and anticancer effects. These activities are mediated through multiple signaling pathways, including Nrf2/ARE, NF-κB, MAPK, PI3K/Akt, and caspase-dependent apoptotic pathways. Recent studies have demonstrated the potential of fucoidan-based nanocarriers for targeted and controlled drug delivery, improving bioavailability, therapeutic efficacy, and tumor targeting. Furthermore, modern pharmacological evidence increasingly supports the traditional use of fucoidan-rich seaweed in TCM. Discussion The therapeutic efficacy of fucoidan is strongly influenced by its structure–activity relationships and physicochemical properties. Despite challenges related to structural heterogeneity, bioavailability, and limited clinical evidence, advances in nanotechnology and biomedical research continue to expand its potential applications. Fucoidan represents a promising marine-derived biomolecule for the development of future pharmaceuticals, nutraceuticals, and targeted therapeutic systems.
Related
- Affibody-based approaches as potential therapeutics for breast cancer: mechanisms, applications, and future perspectives
- Phytochemistry, pharmacology, safety, and applications of Buddleja globosa Hope [Scrophulariaceae]: a systematic review from bioactive metabolites and mechanisms to translational perspectives
- Fine-scale human–flood relationships in the Congo Basin: ethnographic perspectives from the Lac Télé Community Reserve
- Mitochondrial quality control and intestinal barrier dysfunction in inflammatory bowel disease: knowledge mapping and translational perspectives on traditional Chinese medicine-derived bioactive compounds
- Unlocking the therapeutic potential of traditional Chinese medicine in Crohn’s disease: from multi-target mechanisms to clinical promise
BibTeX
@article{lakshmikanthan2026fucoidan,
title = {{Fucoidan: Structure–activity relationships, molecular mechanisms, and nanotherapeutic applications with perspectives from Traditional Chinese Medicine}},
author = {Mythileeswari Lakshmikanthan and Sakthivel Muthu},
journal = {Pharmacological Research - Modern Chinese Medicine},
year = {2026},
month = jun,
doi = {10.1016/j.prmcm.2026.100838},
url = {https://doi.org/10.1016/j.prmcm.2026.100838},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Fucoidan: Structure–activity relationships, molecular mechanisms, and nanotherapeutic applications with perspectives from Traditional Chinese Medicine
AU - Mythileeswari Lakshmikanthan
AU - Sakthivel Muthu
PY - 2026
DA - 2026/06/16
JO - Pharmacological Research - Modern Chinese Medicine
DO - 10.1016/j.prmcm.2026.100838
UR - https://doi.org/10.1016/j.prmcm.2026.100838
AB - Introduction Fucoidan is a sulfated polysaccharide derived from brown macroalgae that has attracted considerable attention due to its diverse biological activities and therapeutic potential. Its bioactivity is closely associated with structural characteristics such as molecular weight, sulfation pattern, monosaccharide composition, and branching architecture. Methods This narrative review summarizes recent advances in fucoidan research, focusing on its sources, structural characteristics, structure–activity relationships, molecular mechanisms, biological activities, nanotherapeutic applications, and perspectives from Traditional Chinese Medicine (TCM). Results Fucoidan exhibits a broad spectrum of biological activities, including antioxidants, anti-inflammatory, anticoagulant, antiviral, immunomodulatory, and anticancer effects. These activities are mediated through multiple signaling pathways, including Nrf2/ARE, NF-κB, MAPK, PI3K/Akt, and caspase-dependent apoptotic pathways. Recent studies have demonstrated the potential of fucoidan-based nanocarriers for targeted and controlled drug delivery, improving bioavailability, therapeutic efficacy, and tumor targeting. Furthermore, modern pharmacological evidence increasingly supports the traditional use of fucoidan-rich seaweed in TCM. Discussion The therapeutic efficacy of fucoidan is strongly influenced by its structure–activity relationships and physicochemical properties. Despite challenges related to structural heterogeneity, bioavailability, and limited clinical evidence, advances in nanotechnology and biomedical research continue to expand its potential applications. Fucoidan represents a promising marine-derived biomolecule for the development of future pharmaceuticals, nutraceuticals, and targeted therapeutic systems.
SN - 2667-1425
ER -